COVID-19 Impact on Global Artemisinine Market Insights, Forecast to 2026
Artemisinine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Artemisinine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Artemisinine market is segmented into
The Artemisinine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Artemisinine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Artemisinine Market Share Analysis
Artemisinine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Artemisinine business, the date to enter into the Artemisinine market, Artemisinine product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Artemisinine market is segmented into
- Extraction from Artemisia annua
- Semisynthetic Artemisinine
- Injections
- Tablets
- Others
The Artemisinine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Artemisinine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Artemisinine Market Share Analysis
Artemisinine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Artemisinine business, the date to enter into the Artemisinine market, Artemisinine product introduction, recent developments, etc.
The major vendors covered:
- Guilin Pharmaceutical
- CAT KHANH
- Novanat Bioresource
- BEEPZ
- KPC Pharmaceuticals
- BIONEXX
- Guangxi xiancaotang
- Sanofi
- Natural Bio-engineering
- Kerui nanhai
1 STUDY COVERAGE
1.1 Artemisinine Product Introduction
1.2 Market Segments
1.3 Key Artemisinine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Artemisinine Market Size Growth Rate by Type
1.4.2 Extraction from Artemisia annua
1.4.3 Semisynthetic Artemisinine
1.5 Market by Application
1.5.1 Global Artemisinine Market Size Growth Rate by Application
1.5.2 Injections
1.5.3 Tablets
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Artemisinine Industry Impact
1.6.1 How the Covid-19 is Affecting the Artemisinine Industry
1.6.1.1 Artemisinine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Artemisinine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Artemisinine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Artemisinine Market Size Estimates and Forecasts
2.1.1 Global Artemisinine Revenue 2015-2026
2.1.2 Global Artemisinine Sales 2015-2026
2.2 Artemisinine Market Size by Region: 2020 Versus 2026
2.2.1 Global Artemisinine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Artemisinine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ARTEMISININE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Artemisinine Sales by Manufacturers
3.1.1 Artemisinine Sales by Manufacturers (2015-2020)
3.1.2 Artemisinine Sales Market Share by Manufacturers (2015-2020)
3.2 Artemisinine Revenue by Manufacturers
3.2.1 Artemisinine Revenue by Manufacturers (2015-2020)
3.2.2 Artemisinine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Artemisinine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Artemisinine Revenue in 2019
3.2.5 Global Artemisinine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Artemisinine Price by Manufacturers
3.4 Artemisinine Manufacturing Base Distribution, Product Types
3.4.1 Artemisinine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Artemisinine Product Type
3.4.3 Date of International Manufacturers Enter into Artemisinine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Artemisinine Market Size by Type (2015-2020)
4.1.1 Global Artemisinine Sales by Type (2015-2020)
4.1.2 Global Artemisinine Revenue by Type (2015-2020)
4.1.3 Artemisinine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Artemisinine Market Size Forecast by Type (2021-2026)
4.2.1 Global Artemisinine Sales Forecast by Type (2021-2026)
4.2.2 Global Artemisinine Revenue Forecast by Type (2021-2026)
4.2.3 Artemisinine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Artemisinine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Artemisinine Market Size by Application (2015-2020)
5.1.1 Global Artemisinine Sales by Application (2015-2020)
5.1.2 Global Artemisinine Revenue by Application (2015-2020)
5.1.3 Artemisinine Price by Application (2015-2020)
5.2 Artemisinine Market Size Forecast by Application (2021-2026)
5.2.1 Global Artemisinine Sales Forecast by Application (2021-2026)
5.2.2 Global Artemisinine Revenue Forecast by Application (2021-2026)
5.2.3 Global Artemisinine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Artemisinine by Country
6.1.1 North America Artemisinine Sales by Country
6.1.2 North America Artemisinine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Artemisinine Market Facts & Figures by Type
6.3 North America Artemisinine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Artemisinine by Country
7.1.1 Europe Artemisinine Sales by Country
7.1.2 Europe Artemisinine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Artemisinine Market Facts & Figures by Type
7.3 Europe Artemisinine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Artemisinine by Region
8.1.1 Asia Pacific Artemisinine Sales by Region
8.1.2 Asia Pacific Artemisinine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Artemisinine Market Facts & Figures by Type
8.3 Asia Pacific Artemisinine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Artemisinine by Country
9.1.1 Latin America Artemisinine Sales by Country
9.1.2 Latin America Artemisinine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Artemisinine Market Facts & Figures by Type
9.3 Central & South America Artemisinine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Artemisinine by Country
10.1.1 Middle East and Africa Artemisinine Sales by Country
10.1.2 Middle East and Africa Artemisinine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Artemisinine Market Facts & Figures by Type
10.3 Middle East and Africa Artemisinine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Guilin Pharmaceutical
11.1.1 Guilin Pharmaceutical Corporation Information
11.1.2 Guilin Pharmaceutical Description, Business Overview and Total Revenue
11.1.3 Guilin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Guilin Pharmaceutical Artemisinine Products Offered
11.1.5 Guilin Pharmaceutical Recent Development
11.2 CAT KHANH
11.2.1 CAT KHANH Corporation Information
11.2.2 CAT KHANH Description, Business Overview and Total Revenue
11.2.3 CAT KHANH Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CAT KHANH Artemisinine Products Offered
11.2.5 CAT KHANH Recent Development
11.3 Novanat Bioresource
11.3.1 Novanat Bioresource Corporation Information
11.3.2 Novanat Bioresource Description, Business Overview and Total Revenue
11.3.3 Novanat Bioresource Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novanat Bioresource Artemisinine Products Offered
11.3.5 Novanat Bioresource Recent Development
11.4 BEEPZ
11.4.1 BEEPZ Corporation Information
11.4.2 BEEPZ Description, Business Overview and Total Revenue
11.4.3 BEEPZ Sales, Revenue and Gross Margin (2015-2020)
11.4.4 BEEPZ Artemisinine Products Offered
11.4.5 BEEPZ Recent Development
11.5 KPC Pharmaceuticals
11.5.1 KPC Pharmaceuticals Corporation Information
11.5.2 KPC Pharmaceuticals Description, Business Overview and Total Revenue
11.5.3 KPC Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 KPC Pharmaceuticals Artemisinine Products Offered
11.5.5 KPC Pharmaceuticals Recent Development
11.6 BIONEXX
11.6.1 BIONEXX Corporation Information
11.6.2 BIONEXX Description, Business Overview and Total Revenue
11.6.3 BIONEXX Sales, Revenue and Gross Margin (2015-2020)
11.6.4 BIONEXX Artemisinine Products Offered
11.6.5 BIONEXX Recent Development
11.7 Guangxi xiancaotang
11.7.1 Guangxi xiancaotang Corporation Information
11.7.2 Guangxi xiancaotang Description, Business Overview and Total Revenue
11.7.3 Guangxi xiancaotang Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Guangxi xiancaotang Artemisinine Products Offered
11.7.5 Guangxi xiancaotang Recent Development
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Description, Business Overview and Total Revenue
11.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi Artemisinine Products Offered
11.8.5 Sanofi Recent Development
11.9 Natural Bio-engineering
11.9.1 Natural Bio-engineering Corporation Information
11.9.2 Natural Bio-engineering Description, Business Overview and Total Revenue
11.9.3 Natural Bio-engineering Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Natural Bio-engineering Artemisinine Products Offered
11.9.5 Natural Bio-engineering Recent Development
11.10 Kerui nanhai
11.10.1 Kerui nanhai Corporation Information
11.10.2 Kerui nanhai Description, Business Overview and Total Revenue
11.10.3 Kerui nanhai Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Kerui nanhai Artemisinine Products Offered
11.10.5 Kerui nanhai Recent Development
11.1 Guilin Pharmaceutical
11.1.1 Guilin Pharmaceutical Corporation Information
11.1.2 Guilin Pharmaceutical Description, Business Overview and Total Revenue
11.1.3 Guilin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Guilin Pharmaceutical Artemisinine Products Offered
11.1.5 Guilin Pharmaceutical Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Artemisinine Market Estimates and Projections by Region
12.1.1 Global Artemisinine Sales Forecast by Regions 2021-2026
12.1.2 Global Artemisinine Revenue Forecast by Regions 2021-2026
12.2 North America Artemisinine Market Size Forecast (2021-2026)
12.2.1 North America: Artemisinine Sales Forecast (2021-2026)
12.2.2 North America: Artemisinine Revenue Forecast (2021-2026)
12.2.3 North America: Artemisinine Market Size Forecast by Country (2021-2026)
12.3 Europe Artemisinine Market Size Forecast (2021-2026)
12.3.1 Europe: Artemisinine Sales Forecast (2021-2026)
12.3.2 Europe: Artemisinine Revenue Forecast (2021-2026)
12.3.3 Europe: Artemisinine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Artemisinine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Artemisinine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Artemisinine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Artemisinine Market Size Forecast by Region (2021-2026)
12.5 Latin America Artemisinine Market Size Forecast (2021-2026)
12.5.1 Latin America: Artemisinine Sales Forecast (2021-2026)
12.5.2 Latin America: Artemisinine Revenue Forecast (2021-2026)
12.5.3 Latin America: Artemisinine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Artemisinine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Artemisinine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Artemisinine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Artemisinine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Artemisinine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Artemisinine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Artemisinine Product Introduction
1.2 Market Segments
1.3 Key Artemisinine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Artemisinine Market Size Growth Rate by Type
1.4.2 Extraction from Artemisia annua
1.4.3 Semisynthetic Artemisinine
1.5 Market by Application
1.5.1 Global Artemisinine Market Size Growth Rate by Application
1.5.2 Injections
1.5.3 Tablets
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Artemisinine Industry Impact
1.6.1 How the Covid-19 is Affecting the Artemisinine Industry
1.6.1.1 Artemisinine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Artemisinine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Artemisinine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Artemisinine Market Size Estimates and Forecasts
2.1.1 Global Artemisinine Revenue 2015-2026
2.1.2 Global Artemisinine Sales 2015-2026
2.2 Artemisinine Market Size by Region: 2020 Versus 2026
2.2.1 Global Artemisinine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Artemisinine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ARTEMISININE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Artemisinine Sales by Manufacturers
3.1.1 Artemisinine Sales by Manufacturers (2015-2020)
3.1.2 Artemisinine Sales Market Share by Manufacturers (2015-2020)
3.2 Artemisinine Revenue by Manufacturers
3.2.1 Artemisinine Revenue by Manufacturers (2015-2020)
3.2.2 Artemisinine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Artemisinine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Artemisinine Revenue in 2019
3.2.5 Global Artemisinine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Artemisinine Price by Manufacturers
3.4 Artemisinine Manufacturing Base Distribution, Product Types
3.4.1 Artemisinine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Artemisinine Product Type
3.4.3 Date of International Manufacturers Enter into Artemisinine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Artemisinine Market Size by Type (2015-2020)
4.1.1 Global Artemisinine Sales by Type (2015-2020)
4.1.2 Global Artemisinine Revenue by Type (2015-2020)
4.1.3 Artemisinine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Artemisinine Market Size Forecast by Type (2021-2026)
4.2.1 Global Artemisinine Sales Forecast by Type (2021-2026)
4.2.2 Global Artemisinine Revenue Forecast by Type (2021-2026)
4.2.3 Artemisinine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Artemisinine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Artemisinine Market Size by Application (2015-2020)
5.1.1 Global Artemisinine Sales by Application (2015-2020)
5.1.2 Global Artemisinine Revenue by Application (2015-2020)
5.1.3 Artemisinine Price by Application (2015-2020)
5.2 Artemisinine Market Size Forecast by Application (2021-2026)
5.2.1 Global Artemisinine Sales Forecast by Application (2021-2026)
5.2.2 Global Artemisinine Revenue Forecast by Application (2021-2026)
5.2.3 Global Artemisinine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Artemisinine by Country
6.1.1 North America Artemisinine Sales by Country
6.1.2 North America Artemisinine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Artemisinine Market Facts & Figures by Type
6.3 North America Artemisinine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Artemisinine by Country
7.1.1 Europe Artemisinine Sales by Country
7.1.2 Europe Artemisinine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Artemisinine Market Facts & Figures by Type
7.3 Europe Artemisinine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Artemisinine by Region
8.1.1 Asia Pacific Artemisinine Sales by Region
8.1.2 Asia Pacific Artemisinine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Artemisinine Market Facts & Figures by Type
8.3 Asia Pacific Artemisinine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Artemisinine by Country
9.1.1 Latin America Artemisinine Sales by Country
9.1.2 Latin America Artemisinine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Artemisinine Market Facts & Figures by Type
9.3 Central & South America Artemisinine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Artemisinine by Country
10.1.1 Middle East and Africa Artemisinine Sales by Country
10.1.2 Middle East and Africa Artemisinine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Artemisinine Market Facts & Figures by Type
10.3 Middle East and Africa Artemisinine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Guilin Pharmaceutical
11.1.1 Guilin Pharmaceutical Corporation Information
11.1.2 Guilin Pharmaceutical Description, Business Overview and Total Revenue
11.1.3 Guilin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Guilin Pharmaceutical Artemisinine Products Offered
11.1.5 Guilin Pharmaceutical Recent Development
11.2 CAT KHANH
11.2.1 CAT KHANH Corporation Information
11.2.2 CAT KHANH Description, Business Overview and Total Revenue
11.2.3 CAT KHANH Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CAT KHANH Artemisinine Products Offered
11.2.5 CAT KHANH Recent Development
11.3 Novanat Bioresource
11.3.1 Novanat Bioresource Corporation Information
11.3.2 Novanat Bioresource Description, Business Overview and Total Revenue
11.3.3 Novanat Bioresource Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novanat Bioresource Artemisinine Products Offered
11.3.5 Novanat Bioresource Recent Development
11.4 BEEPZ
11.4.1 BEEPZ Corporation Information
11.4.2 BEEPZ Description, Business Overview and Total Revenue
11.4.3 BEEPZ Sales, Revenue and Gross Margin (2015-2020)
11.4.4 BEEPZ Artemisinine Products Offered
11.4.5 BEEPZ Recent Development
11.5 KPC Pharmaceuticals
11.5.1 KPC Pharmaceuticals Corporation Information
11.5.2 KPC Pharmaceuticals Description, Business Overview and Total Revenue
11.5.3 KPC Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 KPC Pharmaceuticals Artemisinine Products Offered
11.5.5 KPC Pharmaceuticals Recent Development
11.6 BIONEXX
11.6.1 BIONEXX Corporation Information
11.6.2 BIONEXX Description, Business Overview and Total Revenue
11.6.3 BIONEXX Sales, Revenue and Gross Margin (2015-2020)
11.6.4 BIONEXX Artemisinine Products Offered
11.6.5 BIONEXX Recent Development
11.7 Guangxi xiancaotang
11.7.1 Guangxi xiancaotang Corporation Information
11.7.2 Guangxi xiancaotang Description, Business Overview and Total Revenue
11.7.3 Guangxi xiancaotang Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Guangxi xiancaotang Artemisinine Products Offered
11.7.5 Guangxi xiancaotang Recent Development
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Description, Business Overview and Total Revenue
11.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi Artemisinine Products Offered
11.8.5 Sanofi Recent Development
11.9 Natural Bio-engineering
11.9.1 Natural Bio-engineering Corporation Information
11.9.2 Natural Bio-engineering Description, Business Overview and Total Revenue
11.9.3 Natural Bio-engineering Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Natural Bio-engineering Artemisinine Products Offered
11.9.5 Natural Bio-engineering Recent Development
11.10 Kerui nanhai
11.10.1 Kerui nanhai Corporation Information
11.10.2 Kerui nanhai Description, Business Overview and Total Revenue
11.10.3 Kerui nanhai Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Kerui nanhai Artemisinine Products Offered
11.10.5 Kerui nanhai Recent Development
11.1 Guilin Pharmaceutical
11.1.1 Guilin Pharmaceutical Corporation Information
11.1.2 Guilin Pharmaceutical Description, Business Overview and Total Revenue
11.1.3 Guilin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Guilin Pharmaceutical Artemisinine Products Offered
11.1.5 Guilin Pharmaceutical Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Artemisinine Market Estimates and Projections by Region
12.1.1 Global Artemisinine Sales Forecast by Regions 2021-2026
12.1.2 Global Artemisinine Revenue Forecast by Regions 2021-2026
12.2 North America Artemisinine Market Size Forecast (2021-2026)
12.2.1 North America: Artemisinine Sales Forecast (2021-2026)
12.2.2 North America: Artemisinine Revenue Forecast (2021-2026)
12.2.3 North America: Artemisinine Market Size Forecast by Country (2021-2026)
12.3 Europe Artemisinine Market Size Forecast (2021-2026)
12.3.1 Europe: Artemisinine Sales Forecast (2021-2026)
12.3.2 Europe: Artemisinine Revenue Forecast (2021-2026)
12.3.3 Europe: Artemisinine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Artemisinine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Artemisinine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Artemisinine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Artemisinine Market Size Forecast by Region (2021-2026)
12.5 Latin America Artemisinine Market Size Forecast (2021-2026)
12.5.1 Latin America: Artemisinine Sales Forecast (2021-2026)
12.5.2 Latin America: Artemisinine Revenue Forecast (2021-2026)
12.5.3 Latin America: Artemisinine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Artemisinine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Artemisinine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Artemisinine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Artemisinine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Artemisinine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Artemisinine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Artemisinine Market Segments
Table 2. Ranking of Global Top Artemisinine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Artemisinine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Extraction from Artemisia annua
Table 5. Major Manufacturers of Semisynthetic Artemisinine
Table 6. COVID-19 Impact Global Market: (Four Artemisinine Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Artemisinine Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Artemisinine Players to Combat Covid-19 Impact
Table 11. Global Artemisinine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Artemisinine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Artemisinine Sales by Regions 2015-2020 (K Units)
Table 14. Global Artemisinine Sales Market Share by Regions (2015-2020)
Table 15. Global Artemisinine Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Artemisinine Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Artemisinine Sales Share by Manufacturers (2015-2020)
Table 18. Global Artemisinine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Artemisinine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artemisinine as of 2019)
Table 20. Artemisinine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Artemisinine Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Artemisinine Price (2015-2020) (USD/Unit)
Table 23. Artemisinine Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Artemisinine Product Type
Table 25. Date of International Manufacturers Enter into Artemisinine Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Artemisinine Sales by Type (2015-2020) (K Units)
Table 28. Global Artemisinine Sales Share by Type (2015-2020)
Table 29. Global Artemisinine Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Artemisinine Revenue Share by Type (2015-2020)
Table 31. Artemisinine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Artemisinine Sales by Application (2015-2020) (K Units)
Table 33. Global Artemisinine Sales Share by Application (2015-2020)
Table 34. North America Artemisinine Sales by Country (2015-2020) (K Units)
Table 35. North America Artemisinine Sales Market Share by Country (2015-2020)
Table 36. North America Artemisinine Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Artemisinine Revenue Market Share by Country (2015-2020)
Table 38. North America Artemisinine Sales by Type (2015-2020) (K Units)
Table 39. North America Artemisinine Sales Market Share by Type (2015-2020)
Table 40. North America Artemisinine Sales by Application (2015-2020) (K Units)
Table 41. North America Artemisinine Sales Market Share by Application (2015-2020)
Table 42. Europe Artemisinine Sales by Country (2015-2020) (K Units)
Table 43. Europe Artemisinine Sales Market Share by Country (2015-2020)
Table 44. Europe Artemisinine Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Artemisinine Revenue Market Share by Country (2015-2020)
Table 46. Europe Artemisinine Sales by Type (2015-2020) (K Units)
Table 47. Europe Artemisinine Sales Market Share by Type (2015-2020)
Table 48. Europe Artemisinine Sales by Application (2015-2020) (K Units)
Table 49. Europe Artemisinine Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Artemisinine Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Artemisinine Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Artemisinine Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Artemisinine Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Artemisinine Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Artemisinine Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Artemisinine Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Artemisinine Sales Market Share by Application (2015-2020)
Table 58. Latin America Artemisinine Sales by Country (2015-2020) (K Units)
Table 59. Latin America Artemisinine Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Artemisinine Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Artemisinine Revenue Market Share by Country (2015-2020)
Table 62. Latin America Artemisinine Sales by Type (2015-2020) (K Units)
Table 63. Latin America Artemisinine Sales Market Share by Type (2015-2020)
Table 64. Latin America Artemisinine Sales by Application (2015-2020) (K Units)
Table 65. Latin America Artemisinine Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Artemisinine Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Artemisinine Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Artemisinine Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Artemisinine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Artemisinine Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Artemisinine Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Artemisinine Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Artemisinine Sales Market Share by Application (2015-2020)
Table 74. Guilin Pharmaceutical Corporation Information
Table 75. Guilin Pharmaceutical Description and Major Businesses
Table 76. Guilin Pharmaceutical Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Guilin Pharmaceutical Product
Table 78. Guilin Pharmaceutical Recent Development
Table 79. CAT KHANH Corporation Information
Table 80. CAT KHANH Description and Major Businesses
Table 81. CAT KHANH Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. CAT KHANH Product
Table 83. CAT KHANH Recent Development
Table 84. Novanat Bioresource Corporation Information
Table 85. Novanat Bioresource Description and Major Businesses
Table 86. Novanat Bioresource Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Novanat Bioresource Product
Table 88. Novanat Bioresource Recent Development
Table 89. BEEPZ Corporation Information
Table 90. BEEPZ Description and Major Businesses
Table 91. BEEPZ Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. BEEPZ Product
Table 93. BEEPZ Recent Development
Table 94. KPC Pharmaceuticals Corporation Information
Table 95. KPC Pharmaceuticals Description and Major Businesses
Table 96. KPC Pharmaceuticals Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. KPC Pharmaceuticals Product
Table 98. KPC Pharmaceuticals Recent Development
Table 99. BIONEXX Corporation Information
Table 100. BIONEXX Description and Major Businesses
Table 101. BIONEXX Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. BIONEXX Product
Table 103. BIONEXX Recent Development
Table 104. Guangxi xiancaotang Corporation Information
Table 105. Guangxi xiancaotang Description and Major Businesses
Table 106. Guangxi xiancaotang Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Guangxi xiancaotang Product
Table 108. Guangxi xiancaotang Recent Development
Table 109. Sanofi Corporation Information
Table 110. Sanofi Description and Major Businesses
Table 111. Sanofi Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Sanofi Product
Table 113. Sanofi Recent Development
Table 114. Natural Bio-engineering Corporation Information
Table 115. Natural Bio-engineering Description and Major Businesses
Table 116. Natural Bio-engineering Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Natural Bio-engineering Product
Table 118. Natural Bio-engineering Recent Development
Table 119. Kerui nanhai Corporation Information
Table 120. Kerui nanhai Description and Major Businesses
Table 121. Kerui nanhai Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Kerui nanhai Product
Table 123. Kerui nanhai Recent Development
Table 124. Global Artemisinine Sales Forecast by Regions (2021-2026) (K Units)
Table 125. Global Artemisinine Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Artemisinine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Artemisinine Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Artemisinine Sales Forecast by Country (2021-2026) (K Units)
Table 129. North America: Artemisinine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Artemisinine Sales Forecast by Country (2021-2026) (K Units)
Table 131. Europe: Artemisinine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Artemisinine Sales Forecast by Region (2021-2026) (K Units)
Table 133. Asia Pacific: Artemisinine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Artemisinine Sales Forecast by Country (2021-2026) (K Units)
Table 135. Latin America: Artemisinine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Artemisinine Sales Forecast by Country (2021-2026) (K Units)
Table 137. Middle East and Africa: Artemisinine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Artemisinine Players
Table 142. Artemisinine Customers List
Table 143. Artemisinine Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
Table 1. Artemisinine Market Segments
Table 2. Ranking of Global Top Artemisinine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Artemisinine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Extraction from Artemisia annua
Table 5. Major Manufacturers of Semisynthetic Artemisinine
Table 6. COVID-19 Impact Global Market: (Four Artemisinine Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Artemisinine Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Artemisinine Players to Combat Covid-19 Impact
Table 11. Global Artemisinine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Artemisinine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Artemisinine Sales by Regions 2015-2020 (K Units)
Table 14. Global Artemisinine Sales Market Share by Regions (2015-2020)
Table 15. Global Artemisinine Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Artemisinine Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Artemisinine Sales Share by Manufacturers (2015-2020)
Table 18. Global Artemisinine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Artemisinine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artemisinine as of 2019)
Table 20. Artemisinine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Artemisinine Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Artemisinine Price (2015-2020) (USD/Unit)
Table 23. Artemisinine Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Artemisinine Product Type
Table 25. Date of International Manufacturers Enter into Artemisinine Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Artemisinine Sales by Type (2015-2020) (K Units)
Table 28. Global Artemisinine Sales Share by Type (2015-2020)
Table 29. Global Artemisinine Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Artemisinine Revenue Share by Type (2015-2020)
Table 31. Artemisinine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Artemisinine Sales by Application (2015-2020) (K Units)
Table 33. Global Artemisinine Sales Share by Application (2015-2020)
Table 34. North America Artemisinine Sales by Country (2015-2020) (K Units)
Table 35. North America Artemisinine Sales Market Share by Country (2015-2020)
Table 36. North America Artemisinine Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Artemisinine Revenue Market Share by Country (2015-2020)
Table 38. North America Artemisinine Sales by Type (2015-2020) (K Units)
Table 39. North America Artemisinine Sales Market Share by Type (2015-2020)
Table 40. North America Artemisinine Sales by Application (2015-2020) (K Units)
Table 41. North America Artemisinine Sales Market Share by Application (2015-2020)
Table 42. Europe Artemisinine Sales by Country (2015-2020) (K Units)
Table 43. Europe Artemisinine Sales Market Share by Country (2015-2020)
Table 44. Europe Artemisinine Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Artemisinine Revenue Market Share by Country (2015-2020)
Table 46. Europe Artemisinine Sales by Type (2015-2020) (K Units)
Table 47. Europe Artemisinine Sales Market Share by Type (2015-2020)
Table 48. Europe Artemisinine Sales by Application (2015-2020) (K Units)
Table 49. Europe Artemisinine Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Artemisinine Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Artemisinine Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Artemisinine Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Artemisinine Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Artemisinine Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Artemisinine Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Artemisinine Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Artemisinine Sales Market Share by Application (2015-2020)
Table 58. Latin America Artemisinine Sales by Country (2015-2020) (K Units)
Table 59. Latin America Artemisinine Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Artemisinine Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Artemisinine Revenue Market Share by Country (2015-2020)
Table 62. Latin America Artemisinine Sales by Type (2015-2020) (K Units)
Table 63. Latin America Artemisinine Sales Market Share by Type (2015-2020)
Table 64. Latin America Artemisinine Sales by Application (2015-2020) (K Units)
Table 65. Latin America Artemisinine Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Artemisinine Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Artemisinine Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Artemisinine Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Artemisinine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Artemisinine Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Artemisinine Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Artemisinine Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Artemisinine Sales Market Share by Application (2015-2020)
Table 74. Guilin Pharmaceutical Corporation Information
Table 75. Guilin Pharmaceutical Description and Major Businesses
Table 76. Guilin Pharmaceutical Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Guilin Pharmaceutical Product
Table 78. Guilin Pharmaceutical Recent Development
Table 79. CAT KHANH Corporation Information
Table 80. CAT KHANH Description and Major Businesses
Table 81. CAT KHANH Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. CAT KHANH Product
Table 83. CAT KHANH Recent Development
Table 84. Novanat Bioresource Corporation Information
Table 85. Novanat Bioresource Description and Major Businesses
Table 86. Novanat Bioresource Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Novanat Bioresource Product
Table 88. Novanat Bioresource Recent Development
Table 89. BEEPZ Corporation Information
Table 90. BEEPZ Description and Major Businesses
Table 91. BEEPZ Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. BEEPZ Product
Table 93. BEEPZ Recent Development
Table 94. KPC Pharmaceuticals Corporation Information
Table 95. KPC Pharmaceuticals Description and Major Businesses
Table 96. KPC Pharmaceuticals Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. KPC Pharmaceuticals Product
Table 98. KPC Pharmaceuticals Recent Development
Table 99. BIONEXX Corporation Information
Table 100. BIONEXX Description and Major Businesses
Table 101. BIONEXX Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. BIONEXX Product
Table 103. BIONEXX Recent Development
Table 104. Guangxi xiancaotang Corporation Information
Table 105. Guangxi xiancaotang Description and Major Businesses
Table 106. Guangxi xiancaotang Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Guangxi xiancaotang Product
Table 108. Guangxi xiancaotang Recent Development
Table 109. Sanofi Corporation Information
Table 110. Sanofi Description and Major Businesses
Table 111. Sanofi Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Sanofi Product
Table 113. Sanofi Recent Development
Table 114. Natural Bio-engineering Corporation Information
Table 115. Natural Bio-engineering Description and Major Businesses
Table 116. Natural Bio-engineering Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Natural Bio-engineering Product
Table 118. Natural Bio-engineering Recent Development
Table 119. Kerui nanhai Corporation Information
Table 120. Kerui nanhai Description and Major Businesses
Table 121. Kerui nanhai Artemisinine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Kerui nanhai Product
Table 123. Kerui nanhai Recent Development
Table 124. Global Artemisinine Sales Forecast by Regions (2021-2026) (K Units)
Table 125. Global Artemisinine Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Artemisinine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Artemisinine Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Artemisinine Sales Forecast by Country (2021-2026) (K Units)
Table 129. North America: Artemisinine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Artemisinine Sales Forecast by Country (2021-2026) (K Units)
Table 131. Europe: Artemisinine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Artemisinine Sales Forecast by Region (2021-2026) (K Units)
Table 133. Asia Pacific: Artemisinine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Artemisinine Sales Forecast by Country (2021-2026) (K Units)
Table 135. Latin America: Artemisinine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Artemisinine Sales Forecast by Country (2021-2026) (K Units)
Table 137. Middle East and Africa: Artemisinine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Artemisinine Players
Table 142. Artemisinine Customers List
Table 143. Artemisinine Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Artemisinine Product Picture
Figure 2. Global Artemisinine Sales Market Share by Type in 2020 & 2026
Figure 3. Extraction from Artemisia annua Product Picture
Figure 4. Semisynthetic Artemisinine Product Picture
Figure 5. Global Artemisinine Sales Market Share by Application in 2020 & 2026
Figure 6. Injections
Figure 7. Tablets
Figure 8. Others
Figure 9. Artemisinine Report Years Considered
Figure 10. Global Artemisinine Market Size 2015-2026 (US$ Million)
Figure 11. Global Artemisinine Sales 2015-2026 (K Units)
Figure 12. Global Artemisinine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Artemisinine Sales Market Share by Region (2015-2020)
Figure 14. Global Artemisinine Sales Market Share by Region in 2019
Figure 15. Global Artemisinine Revenue Market Share by Region (2015-2020)
Figure 16. Global Artemisinine Revenue Market Share by Region in 2019
Figure 17. Global Artemisinine Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Artemisinine Revenue in 2019
Figure 19. Artemisinine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Artemisinine Sales Market Share by Type (2015-2020)
Figure 21. Global Artemisinine Sales Market Share by Type in 2019
Figure 22. Global Artemisinine Revenue Market Share by Type (2015-2020)
Figure 23. Global Artemisinine Revenue Market Share by Type in 2019
Figure 24. Global Artemisinine Market Share by Price Range (2015-2020)
Figure 25. Global Artemisinine Sales Market Share by Application (2015-2020)
Figure 26. Global Artemisinine Sales Market Share by Application in 2019
Figure 27. Global Artemisinine Revenue Market Share by Application (2015-2020)
Figure 28. Global Artemisinine Revenue Market Share by Application in 2019
Figure 29. North America Artemisinine Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Artemisinine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Artemisinine Sales Market Share by Country in 2019
Figure 32. North America Artemisinine Revenue Market Share by Country in 2019
Figure 33. U.S. Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Artemisinine Market Share by Type in 2019
Figure 38. North America Artemisinine Market Share by Application in 2019
Figure 39. Europe Artemisinine Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Artemisinine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Artemisinine Sales Market Share by Country in 2019
Figure 42. Europe Artemisinine Revenue Market Share by Country in 2019
Figure 43. Germany Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Artemisinine Market Share by Type in 2019
Figure 54. Europe Artemisinine Market Share by Application in 2019
Figure 55. Asia Pacific Artemisinine Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Artemisinine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Artemisinine Sales Market Share by Region in 2019
Figure 58. Asia Pacific Artemisinine Revenue Market Share by Region in 2019
Figure 59. China Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Artemisinine Market Share by Type in 2019
Figure 82. Asia Pacific Artemisinine Market Share by Application in 2019
Figure 83. Latin America Artemisinine Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Artemisinine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Artemisinine Sales Market Share by Country in 2019
Figure 86. Latin America Artemisinine Revenue Market Share by Country in 2019
Figure 87. Mexico Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Artemisinine Market Share by Type in 2019
Figure 94. Latin America Artemisinine Market Share by Application in 2019
Figure 95. Middle East and Africa Artemisinine Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Artemisinine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Artemisinine Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Artemisinine Revenue Market Share by Country in 2019
Figure 99. Turkey Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Artemisinine Market Share by Type in 2019
Figure 106. Middle East and Africa Artemisinine Market Share by Application in 2019
Figure 107. Guilin Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. CAT KHANH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Novanat Bioresource Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. BEEPZ Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. KPC Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. BIONEXX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Guangxi xiancaotang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Natural Bio-engineering Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Kerui nanhai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. North America Artemisinine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. North America Artemisinine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe Artemisinine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Europe Artemisinine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Asia Pacific Artemisinine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Asia Pacific Artemisinine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Latin America Artemisinine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Latin America Artemisinine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Middle East and Africa Artemisinine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. Middle East and Africa Artemisinine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Porter's Five Forces Analysis
Figure 128. Channels of Distribution
Figure 129. Distributors Profiles
Figure 130. Bottom-up and Top-down Approaches for This Report
Figure 131. Data Triangulation
Figure 132. Key Executives Interviewed
Figure 1. Artemisinine Product Picture
Figure 2. Global Artemisinine Sales Market Share by Type in 2020 & 2026
Figure 3. Extraction from Artemisia annua Product Picture
Figure 4. Semisynthetic Artemisinine Product Picture
Figure 5. Global Artemisinine Sales Market Share by Application in 2020 & 2026
Figure 6. Injections
Figure 7. Tablets
Figure 8. Others
Figure 9. Artemisinine Report Years Considered
Figure 10. Global Artemisinine Market Size 2015-2026 (US$ Million)
Figure 11. Global Artemisinine Sales 2015-2026 (K Units)
Figure 12. Global Artemisinine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Artemisinine Sales Market Share by Region (2015-2020)
Figure 14. Global Artemisinine Sales Market Share by Region in 2019
Figure 15. Global Artemisinine Revenue Market Share by Region (2015-2020)
Figure 16. Global Artemisinine Revenue Market Share by Region in 2019
Figure 17. Global Artemisinine Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Artemisinine Revenue in 2019
Figure 19. Artemisinine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Artemisinine Sales Market Share by Type (2015-2020)
Figure 21. Global Artemisinine Sales Market Share by Type in 2019
Figure 22. Global Artemisinine Revenue Market Share by Type (2015-2020)
Figure 23. Global Artemisinine Revenue Market Share by Type in 2019
Figure 24. Global Artemisinine Market Share by Price Range (2015-2020)
Figure 25. Global Artemisinine Sales Market Share by Application (2015-2020)
Figure 26. Global Artemisinine Sales Market Share by Application in 2019
Figure 27. Global Artemisinine Revenue Market Share by Application (2015-2020)
Figure 28. Global Artemisinine Revenue Market Share by Application in 2019
Figure 29. North America Artemisinine Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Artemisinine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Artemisinine Sales Market Share by Country in 2019
Figure 32. North America Artemisinine Revenue Market Share by Country in 2019
Figure 33. U.S. Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Artemisinine Market Share by Type in 2019
Figure 38. North America Artemisinine Market Share by Application in 2019
Figure 39. Europe Artemisinine Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Artemisinine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Artemisinine Sales Market Share by Country in 2019
Figure 42. Europe Artemisinine Revenue Market Share by Country in 2019
Figure 43. Germany Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Artemisinine Market Share by Type in 2019
Figure 54. Europe Artemisinine Market Share by Application in 2019
Figure 55. Asia Pacific Artemisinine Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Artemisinine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Artemisinine Sales Market Share by Region in 2019
Figure 58. Asia Pacific Artemisinine Revenue Market Share by Region in 2019
Figure 59. China Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Artemisinine Market Share by Type in 2019
Figure 82. Asia Pacific Artemisinine Market Share by Application in 2019
Figure 83. Latin America Artemisinine Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Artemisinine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Artemisinine Sales Market Share by Country in 2019
Figure 86. Latin America Artemisinine Revenue Market Share by Country in 2019
Figure 87. Mexico Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Artemisinine Market Share by Type in 2019
Figure 94. Latin America Artemisinine Market Share by Application in 2019
Figure 95. Middle East and Africa Artemisinine Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Artemisinine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Artemisinine Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Artemisinine Revenue Market Share by Country in 2019
Figure 99. Turkey Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Artemisinine Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Artemisinine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Artemisinine Market Share by Type in 2019
Figure 106. Middle East and Africa Artemisinine Market Share by Application in 2019
Figure 107. Guilin Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. CAT KHANH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Novanat Bioresource Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. BEEPZ Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. KPC Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. BIONEXX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Guangxi xiancaotang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Natural Bio-engineering Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Kerui nanhai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. North America Artemisinine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. North America Artemisinine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe Artemisinine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Europe Artemisinine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Asia Pacific Artemisinine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Asia Pacific Artemisinine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Latin America Artemisinine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Latin America Artemisinine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Middle East and Africa Artemisinine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. Middle East and Africa Artemisinine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Porter's Five Forces Analysis
Figure 128. Channels of Distribution
Figure 129. Distributors Profiles
Figure 130. Bottom-up and Top-down Approaches for This Report
Figure 131. Data Triangulation
Figure 132. Key Executives Interviewed
